Skip to main content
. 2019 Dec 28;21(1):217. doi: 10.3390/ijms21010217

Figure 3.

Figure 3

The patient distribution of the MYC DNA amplification and mRNA high expression by each subtype in TCGA breast cancer patients. MYC DNA amplified tumors (DNA amp(+) as red column) and MYC mRNA high expression tumors (mRNA high as orange column).